Bitfarms Ltd. Files 6-K, Incorporates Exhibits

Ticker: BITF · Form: 6-K · Filed: 2024-12-18T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, registration-statement, compliance

TL;DR

Bitfarms 6-K filed: Exhibits 99.1 & 99.2 incorporated into F-10, 99.1 into S-8. Standard compliance.

AI Summary

Bitfarms Ltd. filed a Form 6-K on December 18, 2024, to report information for the month of December 2024. The filing incorporates by reference certain exhibits into its existing Registration Statements on Form F-10 and Form S-8. Specifically, Exhibit 99.1 and Exhibit 99.2 are incorporated into the Form F-10 registration statement (File No. 333-272989), and Exhibit 99.1 is also incorporated into the Form S-8 registration statement (File No. 333-278868).

Why It Matters

This filing indicates ongoing regulatory compliance and updates to existing registration statements, which is crucial for maintaining the validity of its securities offerings.

Risk Assessment

Risk Level: low — This filing is primarily administrative, incorporating previously disclosed information into existing registration statements, and does not introduce new material risks.

Key Players & Entities

FAQ

What specific information is contained in Exhibit 99.1 and Exhibit 99.2 that is being incorporated by reference?

The provided text does not specify the content of Exhibits 99.1 and 99.2, only that they are incorporated by reference into the mentioned registration statements.

What is the purpose of incorporating exhibits into a Form F-10 or Form S-8 registration statement?

Incorporating exhibits into registration statements updates or supplements the information available to investors regarding the securities being offered or previously registered.

When was the Form 6-K filed with the SEC?

The Form 6-K was filed on December 18, 2024.

What is the Commission File Number for Bitfarms Ltd.?

The Commission File Number for Bitfarms Ltd. is 001-40370.

Does this filing indicate any new business developments or financial changes for Bitfarms Ltd.?

No, this filing is primarily for administrative purposes, incorporating existing exhibits into registration statements, and does not disclose new business developments or financial changes.

From the Filing

0001213900-24-109907.txt : 20241218 0001213900-24-109907.hdr.sgml : 20241218 20241217210052 ACCESSION NUMBER: 0001213900-24-109907 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20241217 FILED AS OF DATE: 20241218 DATE AS OF CHANGE: 20241217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bitfarms Ltd CENTRAL INDEX KEY: 0001812477 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] ORGANIZATION NAME: 09 Crypto Assets IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40370 FILM NUMBER: 241557436 BUSINESS ADDRESS: STREET 1: 110 YONGE STREET STREET 2: SUITE 1601 CITY: TORONTO STATE: A6 ZIP: M5C 1T4 BUSINESS PHONE: 647-259-1790 MAIL ADDRESS: STREET 1: 110 YONGE STREET STREET 2: SUITE 1601 CITY: TORONTO STATE: A6 ZIP: M5C 1T4 6-K 1 ea0225130-6k_bitfarms.htm REPORT OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-40370 BITFARMS LTD. (Translation of registrant’s name into English) 110 Yonge Street, Suite 1601, Toronto, Ontario, Canada M5C 1T4 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐ Form 40-F ☒ DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K Exhibit 99.1 of this Report on Form 6-K is incorporated by reference into the Registration Statements of Bitfarms Ltd. on Form F-10 (File No. 333-272989 ) and Form S-8 (File No. 333-278868 ), each as amended or supplemented. Exhibit 99.2 of this Report on Form 6-K is incorporated by reference into the Registration Statement of Bitfarms Ltd. on Form F-10 (File No. 333-272989 ), as amended or supplemented. Exhibit 99.3 of this Report on Form 6-K is incorporated by reference into the Registration Statements of Bitfarms Ltd. on Form F-10 (File No. 333-272989 ), Form S-8 (File No. 333-278868 ) and Form F-4 (File No. 333-282657 ), each as amended or supplemented. See the Exhibits listed below. Exhibits Exhibit No. Description 99.1 Consent of PricewaterhouseCoopers LLP 99.2 Consent of Urish Popeck & Co., LLC 99.3 Material Change Report dated December 17, 2024 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BITFARMS LTD. By: /s/ Ben Gagnon Name: Ben Gagnon Title: Chief Executive Officer Date: December 17, 2024 2 EX-99.1 2 ea022513001ex99-1_bitfarms.htm CONSENT OF PRICEWATERHOUSECOOPERS LLP Exhibit 99.1 Con sent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in the Registration Statements on Form F-10 (No. 333-272989), as amended, and on Form S-8 (No. 333-278868) of Bitfarms Ltd. of our report dated December 9, 2024 relating to the consolidated financial statements, which appears in Exhibit 99.2 to Amendment No. 1 to Bitfarms Ltd.’s Annual Report on Form 40-F for the year ended December 31, 2023. /s/ PricewaterhouseCoopers LLP Chartered Professional Accountants, Licensed Public Accountants Toronto, Canada December 17, 2024 EX-99.2 3 ea022513001ex99-2_bitfarms.htm CONSENT OF URISH POPECK & CO., LLC Exhibit 99.2 Consent of Independent Registered Public Accounting Firm We hereby consent to the use in the second amended and restated prospectus supplement dated December 17, 2024, amended and restating the prospectus supplement dated March 8, 2024, as first amended and restated by the prospectus supplement dated October 4, 2024 relating to the US$86,913,570 at-the-market offering of common shares of Bitfarms Ltd. (the “Company”) together with the accompanying short form base shelf prospectus dated No

View on Read The Filing